SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Addiction Medicine Referral — Judy Garland — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJudy Garland
Date of birth1922-06-10
IdentifiersMRN HR-ML005-SYN-TD; SSN (made up) 000-05-6127
Document date1955-06-22
AuthorMargaret Ellsworth-Diaz, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Long-term dependence on prescribed secobarbital and dextroamphetamine that began with pills given to her as a teenage performer, in a 33-year-old singer three months after childbirth, with depression and anxiety. Please confirm the diagnoses and advise on a safe way to withdraw the barbiturate and stop the stimulant. [S]

Urgency: Within one week, on the same day as her one-week primary care visit. [S]

Questions for the consultant:

History of Present Illness

Given stimulant and sleeping pills since her teens; for years she has taken secobarbital 200 mg at bedtime, sometimes 300 mg, and dextroamphetamine 10 mg each morning with extra tablets on long working days, from three prescribers at two pharmacies, as the prescription drug monitoring program confirms. She has tried to cut down on her own and could not sleep. No opioids, benzodiazepines or pills from outside a pharmacy; urine drug test shows barbiturates and amphetamine only. No withdrawal seizures known. DAST-10 6, AUDIT-C 2. PHQ-9 14 (item 9 scored 0), GAD-7 13, Mood Disorder Questionnaire negative; structured safety assessment shows no current suicidal thoughts; suicide attempts were reported in earlier years. Third child born three months ago; not breastfeeding; pregnancy test negative. Pulse 98, blood pressure 128/84; ECG normal. Today: prescriptions moved to this clinic alone, seven days at a time; secobarbital continued at 200 mg at bedtime and dextroamphetamine at 10 mg each morning with no extra doses; sertraline 25 mg started; medroxyprogesterone injection given; CBT for insomnia and psychotherapy arranged. Blood test results from today attached [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

3 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Secobarbital 100 mg oral capsule, two capsules (200 mg) at bedtime; prescribed elsewhere for years; continued by this clinic at the verified dose, seven days at a time, until a supervised withdrawal is planned with addiction medicineTwo capsules at bedtime; no extra dosesOral route1955-06-22 to 1955-07-06completedS
Dextroamphetamine 10 mg oral tablet, one tablet each morning; no extra doses; prescribed elsewhere for weight and energyOne tablet each morningOral route1955-06-22 to 1955-07-20completedS
Sertraline 25 mg oral tablet, one tablet dailyOne tablet dailyOral route1955-06-22 to 1955-06-29completedS
Medroxyprogesterone acetate 150 mg/mL injection, 150 mg into the muscle every 13 weeks150 mg intramuscularly every 13 weeksIntramuscular route1955-06-22activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Sedative, hypnotic, or anxiolytic use disorder (barbiturate), moderate, with physiological dependence; began with sleeping pills given in adolescence; synthetic modern episode linked to her documented lifelong dependence on prescribed sleeping pillsactiveconfirmed F13.20S — Synthetic modern coding. Tolerance and withdrawal are not counted toward the diagnosis for a medicine taken under medical supervision; five other criteria are met. Person-first language; not a claim about her real diagnosis.
Stimulant use disorder (prescribed amphetamine), mild; began with stimulants given in adolescence for weight and energy; synthetic modern episode linked to her documented pep pillsactiveconfirmed F15.10S — Synthetic modern coding; DSM-5-TR mild stimulant use disorder maps to F15.10. Tolerance and withdrawal are not counted for a supervised prescription.
Chronic insomnia disorder, long-standing, with sleep tied to sleeping pills since adolescenceactiveconfirmed G47.00S — Synthetic modern diagnosis anchored to the documented sleeping pills.
Contraception three months after childbirth while starting an enzyme-inducing drug: injectable progestin chosen because barbiturates, including any used for the withdrawal, weaken contraceptive pills, patches, rings and implantsactiveconfirmed Z30.013S — Synthetic contraception need; the birth is documented.
Major depressive disorder, single episode, moderate, with anxious distress; Mood Disorder Questionnaire negative and no history of mania or hypomaniaactiveconfirmed F32.1S — Synthetic modern diagnosis; not a claim about her real mood. The roster's bipolar disorder lead is not supported by the sources read and is not used.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
by 1939Stimulant pills for appetite and energy and barbiturate sleeping pills given to her as a teenage studio performer, with dependence on prescribed medicines sinceD (CLM-0003, CLM-0005)
1949Hospital and sanitarium stays in her twenties, publicly described as treatment for exhaustionD (CLM-0007)
1950Suicide attempts reported publicly, including one in 1950; recorded without detailD (CLM-0006)
March 1955Birth of her third child three months before the index visitD (CLM-0010)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
1955-06-22Body height151cmS
1955-06-22Body weight46.5kgS
1955-06-22Body mass index (BMI) [Ratio]20.4kg/m2S
1955-06-22Systolic blood pressure128mm[Hg]S
1955-06-22Diastolic blood pressure84mm[Hg]S
1955-06-22Heart rate98/minS
1955-06-22Respiratory rate16/minS
1955-06-22Body temperature36.8CelS
1955-06-22Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1955-06-22Hemoglobin [Mass/volume] in Blood12.3g/dL12-15.5 g/dLNormalS
1955-06-22MCV [Entitic mean volume] in Red Blood Cells by Automated count86fL80-100 fLNormalS
1955-06-22Platelets [#/volume] in Blood by Automated count28410*3/uL150-400 10*3/uLNormalS
1955-06-22Ferritin [Mass/volume] in Serum or Plasma24ng/mL15-150 ng/mLNormalS
1955-06-22Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
1955-06-22Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
1955-06-22Creatinine [Mass/volume] in Serum or Plasma0.66mg/dL0.59-1.04 mg/dLNormalS
1955-06-22Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1950)/1.73 sq M119mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1955-06-22Glucose [Mass/volume] in Serum or Plasma82mg/dL70-99 mg/dLNormalS
1955-06-22Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L10-35 U/LNormalS
1955-06-22Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-35 U/LNormalS
1955-06-22Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma24U/L5-40 U/LNormalS
1955-06-22Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4.5 mIU/LNormalS
1955-06-22Total score [DAST-10]6{score}S
1955-06-22Total score [AUDIT-C]2{score}S
1955-06-22Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]14{score}S
1955-06-22Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]13{score}S

Assessment

Plan of Treatment